Neurological Disorders & Stroke

Felipe Padilla Vazquez Specialist in Neurointervention, Neuropathic Endovascular Therapy, Cerebrovascular Diseases, Column Surgery, CNS Oncological Surgery, Headaches, Neuropathic Pain and present time he is Member of the Mexican Society of Neurological Surgery AC.

Stroke, TBI, Dementia

Dr Javier Cuevas is a Professor of College of Medicine Family Medicine, Professor, Department of Molecular Pharmacology and Physiology, College of Medicine Professor, Pharmaceutical Sciences, College of Pharmacy Assoc Professor, Cop Dept of Pharmaceutical Science Associate Professor, Department of Molecular Pharmacology and Physiology, College of Medicine Member, Department of Molecular Pharmacology and Physiology Executive Committee, College of Medicine Professor, College of Medicine Molecular Pharmacology & Physiology Member, Neuroscience Signature Program Executive Committee, College of Medicine Member, Diversity and Equal Opportunity Office

Exploring overlapping molecular mechanisms involved in expansion of the ischemic core in large-vessel stroke and infarct coalesces in lacunar infarcts

Felipe Padilla Vazquez Specialist in Neurointervention, Neuropathic Endovascular Therapy, Cerebrovascular Diseases, Column Surgery, CNS Oncological Surgery, Headaches, Neuropathic Pain and present time he is Member of the Mexican Society of Neurological Surgery AC.

Stroke, TBI, Dementia

Sylvain Doré, PhD is a Professor and Program Director of Research Operations in the Department of Anesthesiology, as well as Professor of Neurology, Psychiatry, Pharmaceutics, and Neuroscience, at the University of Florida, College of Medicine. Dr. Doré attained his PhD, in biomedical science, from the University of Montreal and an MS degree in pharmacology at the University of Quebec. He received post-PhD training in psychiatry at McGill University, as well as post-PhD training in neuroscience at Johns Hopkins University. Dr. Doré’s research pertains to studying new effective mechanisms that limit neuronal dysfunction associated with ischemic and hemorrhagic stroke, Alzheimer disease (AD), aging, and various other neurological disorders. His objective is focused on understanding the protective role of heme metabolites in the brain using cellular/molecular techniques and various models of stroke, Alzheimer disease, and aging. New knowledge is gained specifically, by investigating the action and the role of activity of the heme oxygenase enzyme and its unique bioactive metabolites, namely, carbon monoxide, iron, biliverdin, and bilirubin. His overall goal is to slow down the progression of the disease, and ultimately stop it.

Neurodigenerative disorders, ischemic stroke, Alzheimer’s disease, aging, heme oxygenase, prostaglandins.

Dr. Bradley S Duhon is a Neurosurgery Specialist in Parker, Colorado. He graduated with honors from University Of Texas Medical School At Houston in 2004. Having more than 13 years of diverse experiences, especially in NEUROSURGERY, Dr. Bradley S Duhon affiliates with many hospitals including University Of Colorado Hospital Authority, Parker Adventist Hospital, and cooperates with other doctors and specialists in many medical groups including University Physicians Incorporated, Neurosurgical And Spine Specialists. He is currently a member of Congress of Neurological Surgeons (CNS) and American Association of Neurological Surgeons (AANS).

Neurological Surgery, Spine Surgery

Dr. Bryan E Kolb completed his PhD degree from Pennsylvania State University. . Dr. Kolb received a Queen’s Diamond Jubilee Medal from Royal Society of Canada at 2013. Kolb was awarded a Killam Fellowship from the Canada Council and is a Fellow of the Royal Society of Canada. He is a former President of the Canadian Society for Brain, Behavior, and Cognitive Science and former President of the Experimental Division of the Canadian Psychological Association. He is currently a member of the Canadian Institute for Advanced Research’s program in Child and Brain Development. Bryan Kolb has published 5 books, including two textbooks with Ian Whishaw (Fundamentals of Human Neuropsychology, 7th Edition; Introduction to Brain and Behavior, 4th Edition), and over 350 articles and chapters.

Brain plasticity and behavior. Bryan Kolb’s research focuses on how neurons in the cerebral cortex change in response to experiences, drugs, hormones and injury, and how these changes influence behaviour. Over the past 40 years he has identified the ‘rules’ that govern the effects of cerebral injury at different developmental ages. His work has fueled new treatments to help victims of cerebral injury. Kolb was the first to demonstrate how new brain cells grow to restore cerebral function both in development and adulthood and the first to show (with Terry Robinson) that psychoactive drugs produce permanent changes in neuronal structure in cerebral structures and that these changes influence later brain plasticity.

Dr. Kim-Tenser is board certified in neurology, vascular neurology, and neurocritical care. She specializes in the diagnosis and management of patients with stroke and those who are neurocritically ill requiring admission into the neurosciences ICU (ie: GBS, SE, myasthenic crises, SAH, ICH, AVM's, spinal cord injury.

Dr. Kim-Tenser's research interests include the management of intracerebral hemorrhage, stroke outcome/genetics, subarachnoid hemorrhage, hypothermia, and neuroprotection in stroke.

Dr. Adham S Kamel is a Neurology Specialist in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures based at Syracuse, New York. He graduated with honors in 1996 at Medical School: Cairo University, Egypt. Having more than 21 years of diverse experiences, especially in NEUROLOGY, Dr. Adham S Kamel affiliates with many hospitals including University Of Texas Medical Branch, Auburn Community Hospital. He had done his neurology residency at Allegheny General Hospital, Pittsburgh PA. His specialties are neurology, vascular neurology, electrophysiology EEG.

Stroke, Interventional Neurology, Stem cell

Wuwei (Wayne) Feng completed neurology residency training at MUSC, followed by a stroke fellowship at Beth Israel Deaconess Medical Center/Harvard Medical School. He is board certified in general neurology as well as stroke neurology, and is specialized in young stroke diagnosis and management, stroke recovery, and rehabilitation. Additionally, Dr. Feng runs a first of its kind clinic in South Carolina - Post-Stroke Spasticity Clinic. Dr. Feng's research focuses on stroke motor recovery and his research is funded by NIH, AHA as well as industry. He is the stroke rehabilitation award winner from international Stroke Conference 2015 and the Franz Gerstenbrand Award winner from World Federation of Neurorehabilitation 2016. He has published numerous papers and has presented his research at regional, national, and international conferences. His philosophy on stroke care is "We will work together to get you better and stroke free."

Stroke rehabilitation and recovery including spasticity management, Stroke in middle age population (diagnosis, management and recovery), Tele-stroke consultation

Mr. Alejandro De la Parra Solomon is an entrepreneur focused on Information Technology, Education and Health. He is creative and results-driven and has 16+ years of Digital Strategy experience in architecture and implementation. Mr. De la Parra is the COO and Co-founding Partner at The Solomon Brokerage Firm. He currently leads as CEO at Mass Media Dynamics and De la Parra Mobile Solutions and is former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil. Moreover, he is COO & Co-founder at RegenerAge® Clinic & RegenerAge® Beauty, the Digital Strategy Director & Co-founder at Dr. Jois®, BiorganicAging®, What Skin Needs™/WSN International Pty. Ltd. He also serves as current CMO at ReAnima Advanced Biosciences and is the Digital Media Director at Bioquark, Inc. He is also the former Latin America Region Manager and Digital Strategy adviser at CardiacSense and former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, Mr. De la Parra is a Senior Partner, Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, Member of the WAMS Executive Council (WAMS Executive Board), Member of the WAMS Education & Training Board (ETB), Member of the WAMS Editorial Board, Honorary Member of the Academy Faculty FWAMS, WAMS Digital Strategy Chairman & Fellow of the Academy. Moreover, Mr. De la Parra acts as the Chief Operating Officer and is a Co-founding Partner at The Reprogramming Medicine Association. Mr. De la Parra is also a member of the National Introducing Brokers Association and a part of the National Biofuel Board, (Alliance Program), also being the founder and former Board of Directors member of Astrum Fundación, an Advisory Board member of the Lifeboat Foundation, an Advisory Board member of the Future Worlds Center - Cyprus Neuroscience & Technology Institute (Senior TV Program), a Federated member of the International Longevity Alliance, and volunteered as Digital Strategy adviser at the Major Mouse Testing Program. He is also a member of the Web Committee at the Life Extension Advocacy Foundation / Lifespan.io and has volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy.

Cell Regeneration, Biosciences

Dr. Vijay K Sharma is the current recipient of the prestigious Clinician Scientist Award from National Medical Research Council, Singapore. He has published 187 peer reviewed scientific papers and 19 book chapters. Dr. Sharma is Associate Editor for BMC Neurology and serves on the editorial boards of many scientific journals including Stroke, Journal of Stroke, Neural Regeneration Research, Recent Patents on Medical Imaging, Journal of Behavioral and Brain Science, World Journal of Hypertension, ISRN Neurology, American Journal of Cardiovascular Diseases, World Journal of Neurology, Journal of Neurology & Translational Neuroscience (JNTN), International Journal of Medical Sciences and Biotechnology, Advances in Neuroscience Research and Neurological Research and Therapy.

Thrombolysis in acute stroke, especially sonothrombolysis, Blood pressure management in acute ischemic stroke, Advanced applications of transcranial Doppler in cerebrovascular diseases, Intracranial stenosis, Assessment of cerebral hemodynamics with cerebrovascular ultrasonography.

Dr Girouard completed her PhD in cardiovascular physiology in 2002 at the Université de Montreal under the supervision of Dr J. de Champlain, a specialist in the field of hypertension. She then pursued with two fellowships both on the study of cerebrovascular regulation: one at the Weill Medical College of Cornell University and a second one at the University of Vermont under the supervisions of Dr. Costantino Iadecola and Dr Mark T. Nelson, respectively. She is now associate professor at the Department of pharmacology and physiology at the Université de Montréal and the director of the laboratory of neurovascular pharmacology since 2008. Along her career, Dr Girouard received prices including the Merck New investigator price of the ‘Société Québécoise d’Hypertension Artérielle’ and the Young Investigator Award from the Heart and Stroke Foundation of Canada. She recently was nominated Fellow of the American Heart Association. She is involved in many Societies related to Hypertension and neurosciences in particular the ‘Société Québécoise d’Hypertension Artérielle’ and the ‘International Society of Cerebral Blood Flow and Metabolism’ in which she is member of the Board of Directors.

The research interests of Dr Girouard are the study of the mechanisms underlying cerebrovascular regulation in health and diseases especialy in the context of hypertension and arterial stiffness. The main objective of her research is to find therapeutical targets to protect the brain from vascular diseases. To reach this objective, she is using various techniques from molecular biology to brain imaging in mice and humans. She published mostly in the field of hypertension and cerebrovascular regulation.

Dr. Abilash Haridas is Chief of Pediatric Neurosurgery in the department of Neurosurgery at Wayne State University School of Medicine. He is a pediatric neurosurgeon specializing in cerebrovascular, skull base, endoscopic, and epilepsy surgery. After completion of medical school, he went on to post-graduate training in General Surgery at the Brooklyn Hospital Center in New York. He switched career paths to Neurosurgery and spent a year at Harvard University as he transitioned into Neurosurgery. In 2006, he joined the prestigious Mount Sinai Hospital Neurosurgery Residency program in New York City, under the direction of Dr. Kalmon Post and Dr. Joshua Bederson. Following residency he travelled to Chicago in 2011 for a Pediatric Neurosurgery Fellowship at Lurie Childrens Hospital of Northwestern University under the direction of Dr. Tadanori Tomita. In 2012 he completed an additional Cerebrovascular Fellowship at the University of Illinois in Chicago with Dr. Fady Charbel, specializing in complex cerebral bypass and aneurysm surgeries. In 2013, he joined the faculty at Wayne State University and Childrens Hospital of Michigan, bringing his rare expertise in pediatric cerebrovascular diseases.

Epilepsy, Critical Care, Oncology, Pediatric Neurosurgery, Skull Base Surgery, Vascular Neurosurgery

Dr. Moonis graduated from the Univ Coll of Med Sciences, Delhi Univ, New Delhi, Delhi, India in 1982. He works in Worcester, MA and specializes in Neurology. Dr. Moonis is affiliated with HealthAlliance Hospital Leominster and UMASS Memorial Medical Center.he has a Fellowship in Neurology of Aging and Dementia, Clinical Neurophysiology from University of Massachusetts Memorial Medical Center. Dr. Moonis is certified with American Board of Psychiatry and Neurology; Professor, Department of Neurology and Psychiatry, University of Massachusetts Memorial Medical Center; Member of the Royal College of Physicians of Ireland, (Certified), American Board of Clinical Neurophysiology I; American Board of Sleep Medicine; Director of the Acute Stroke Program and Stroke Prevention Clinic at the University of Massachusetts Memorial Medical Center, Director, Day Kimball Hospital Sleep Disorder Center; Director, Vascular Fellowship Program, UMass Medical Center; President, Board of Directors of Central Massachusetts.

Health care disparities relating to race, age and gender in stroke and dementia, optimal management and effects on primary and secondary stroke prevention, genetic markers in cryptogenic stroke to aid in sub-classification and management, clinical trials in acute stroke and stroke prevention, data mining in sleep related disorders, and stroke.

Scientist with in depth knowledge and hands on experience in stem cell biology and neurodenerative disorders such as Alzheimer's disease and Frontotemporal dementia. Always interested in potential collaborations and new career opportunities. Currently working at Copenhagen University as Associate Professor and Scientific Project Manager for Stemmad, Neurostem and Brainstem. Hands on experience with organizing research amongst different groups all over Europe in order to fulfill milestones and deliverables of several EU and local grants; including periodic and final reporting. My scientific work includes basic research using neurons derived from human induced pluripotent stem cells to develop in vitro disease models and identify novel disease mechanisms as well as overlapping pharmaceutical targets amongst neurodegenerative diseases. As a scientific project manager I am striving to streamline research and collaboration amongst our involved partners, write scientific progress reports and ensure completion of milestones and deliverables.

-Neurodegenerative Diseases - Human, mouse and porcine stem cell biology (adult, embryonic and iPS cells) - Neural differentiation and neurodegenerative disorders (Alzheimers disease, Frontotemporal dementia and Huntington's disease) - Pancreas development, specifically analysis of transcription factors in pancreatic cell lineage commitment - Human genetics with a focus on X-linked mental retardation

Karen Postal is the president of the American Academy of Clinical Neuropsychology. She is a past president of the Massachusetts Psychological Association and Massachusetts Neuropsychological Society. Dr. Postal is board certified in both clinical neuropsychology and pediatric neuropsychology, reflecting her lifespan practice dedicated to helping people think better in school, at work, and throughout later life. She is a clinical instructor at Harvard Medical school where she teachers postdoctoral fellows in neuropsychology.

Neuropsychology & Pediatric Neuropsychology

Dr. Ricardo is one of the world-class scientist recognized in the field of neurosciences for his unified theory of Alzheimer's disease (EA) and innovative technologies for its prevention, early diagnosis and treatment. Doctor of Science at the University of Chile, and in Biomedicine at the University of Colorado, Postdoctoral Degree at NIH and at the University of Colorado Health Sciences Center. Its successful approach has allowed to bring basic knowledge (R & D itself) to the generation of technological products. Author of relevant developments in neuroimaging, biomarkers and treatment of AD. He was Professor of Biophysics, U Colorado MedSchool and Visiting Professor at NIH, University of Gotebörg and Max Plank Institute. He has also served as Visiting Professor in several centers around the world.Dr. Maccioni is among the 5 Chilean scientists with the greatest impact in the world and has made one of the most important contributions to position Chile in the world science scene, contributing to the important public policies in the prevention of the disorders degenerative diseases of the brain.

Alzheimer’s disease (AD) and other neurodegenerative disorders

Ismail Hakki was born in 1954 in Trabzon. Elementary school Maçka completed middle and high school education in Trabzon. After completing Ataturk University Faculty of Medicine, he started as an assistant at Brain Surgery Department. After continuing his specialization at the Faculty of Medicine of Istanbul University, Department of Neurosurgery, Professor at the Neurosurgery Clinic of Zurich University. Dr. Mahmut Gazi completed his studies on micro neurosurgery beside Yasargil. He served as an Instructor at the Zurich Micro Neurosurgery Research Center, and was also involved in research in Cerebro-vascular microsurgery. He returned to Turkey at the end of 1984 and was appointed to the Presidency of the Department of Neurosurgery at Ataturk University Medical Faculty. In 1985, he first founded the University of Micro Neurosurgery Research Laboratory in Turkey. In addition to Switzerland, he has been researching at different times in Germany, France, England, Austria, Belgium, Holland, Italy, Spain, Yugoslavia, Canada, USA and Japan. In 1988, TUBITAK received the TUBITAK award in 1990 for the first time in the world to develop a new surgical technique used in the operations of brain-artery occlusions, which was literally translated in its own name. In 1991, the United States was awarded the Congress of Neurological Surgeons' INTERNATIONAL FELLOW and FCNS title for his research and contributions to surgical treatment of brain hemorrhages and aneurysms. In the same year, he was awarded by RECTORS and DECISION. AYDIN won the TURKISH NEUROSURGERY RESEARCH AWARD in 1992. The same year, he was elected to the European Stroke Science Council. In the American Stroke Council, he was given the INTERNATIONAL SCIENTIST MAN and FICA DEPARTMENT. In 1992, 1993, 1994 and 1995, he received the US Continuing Medical Education Credit Awards in Neurosurgery. In 1993, he became the first Turkish and first Muslim scientist to enter the Council by electing the Congress of Neurological Surgeons INTERNATIONAL BOARD OF DIRECTORS, as well as members of the Council of Brain Tumors, the Cerebrovascular Surgery Section and many other scientific and administrative boards in the United States. As an invited lecturer, Professor Aydin participated in many international conferences and participated in the publishing boards of scientific journals. He is the OFFICIAL LECTURER of New York Science Academy's Active, AANS 'International Member and 1994 International Skull Base Surgery Congress, was elected to the International Science Council. In 1996, the US received a Neurosurgeon Continuing Education Award with very high credit. With the cause of a research done in 1997, it was COVER to an International Neurosurgical Journal. 1999 received the Turkish Neurosurgery Award. The International Conference of the Year 2000 was selected by the United States Department of Neurosurgery (CNS). Overseas and in our country, many institutions and organizations have been appreciated and rewarded many times. In 2001 in Hidistan, due to the contributions of the Dream Science, it was transformed with CRYSTAL KÃœRE. In 2002 he was invited to Yemen, where he gave many lectures and conferences, and performed educational surgeries. In 2004, she participated in the Pakistan Brain Surgery Congress as a SURF TARGET and gave various conferences. It was abridged here with "ANNUAL AWAR 2004". At international level, more than 200 domestic and foreign scientific studies. Dr. Ismail Almighty Aydin, to this day, many Doctors, Brain Surgeons, Assist. Professor, Associate Professor and Professor. The surgical techniques developed and developed by leading scientists of the world, both abroad and in books and articles, have been included in classical books. Professor AYDIN is also present in the evaluation and decision boards of various scientific organizations besides his duty in Atatürk University Brain Surgery Department. He also works as the President of CNS 'INTERNATIONAL ASSOCIATION AND NERVOUS SYSTEM SURGERY ASSOCIATION in the USA. He is married, has three children, He speaks four foreign languages.

Cerebrovascular and Anatomical Neurosurgery

Dr. Omar is a US Board-Certified Neurologist and Neurological Oncologist. He also has subspecialized training in Endovascular Neurosurgery from the University of Oxford. Dr. Omar's main area of interest is the development of innovative approaches for the management of brain and spinal cord malignancies. He has a unique set of skills that spans across the various disciplines of Neurosciences. He received training in Endovascular Neurosurgery (University of Oxford), Neurological Oncology (University of Toronto), Neurology (University of Missouri - Columbia), Epilepsy / Epilepsy surgery evaluations, EEG, intraoperative monitoring, subdural grids and depth electrode interpretation (Cleveland Clinic Foundation) and Cellular and Molecular Neuroscience (PhD, University of Ottawa). He is a member of the Society for NeuroOncology (SNO), American Medical Association, American Physiological Society (Inactive), The Society for Neuroscience (Inactive) and the American Academy of Neurology (AAN). He is also the recipient of numerous awards including the "Medical Innovator - 2013 Award" from the Sangamon County Medical society for his discovery of a novel molecularly targeted approach for the treatment of spinal cord hemangioblastomas, Excellence Scholarship in Science and Engineering from the University of Ottawa, Prize for Outstanding Achievements from the Ottawa Hospital Foundation and a highly coveted Canadian Institutes of Health Research National Fellowship Award for investigating the role of endogenous neural stem cells in brain repair following ischemic and traumatic brain injury.

Dr. Omar's main area of interest is the development of innovative approaches for the management of brain and spinal cord malignancies.

Dr Torne is among the few super specialists who have been internationally trained in the field of Paediatric Neurology. At present Dr Torne is Head of Department of Neurosciences at Surya Children’s Hospital in Mumbai, India Dr Torne has completed her Fellowship in Paediatric Neurology and Epilepsy from Maharashtra University Health Sciences at Lokmanya Tilak Municipal Hospital and Lokmanya Tilak Municipal Medical College, Mumbai. She has had a brief stint at the University College London Hospital, a premier academic institution cum hospital in the UK. She has been trained in Paediatric Neurology at Birmingham Childrens Hospital where she successfully completed her International Fellowship in Paediatric Neurology, Epilepsy and Neurorehabilitation. To complement her advanced training in Paediatric Neurology she has completed many prestigious International courses like British Paediatric Epilepsy Training Course, British Paediatric Movement disorder Training Course in UK. She has also been trained for Ketogenic diet for drug resistant childhood epilepsies at the Asian Institute of Ketogenic Diet. Dr Torne has many accolades to her name which complements her meticulous and explicate personality. She has to her credit valuable publications in reputed peer reviewed International Journals. She has presented many national and international papers in Cambridge, Birmingham, Italy, France and Hungary. She is affiliated to many International and National Paediatric Neurology and Epilepsy associations. She was honoured by International Bursary from European Paediatric Neurology Society with an opportunity to attend one of the prestigious courses in Paediatric Neuromuscular disorder and Neonatal Neurology at Budapest in Hungary. She was invited to attend the valuable Movement Disorder International Winter School Course by Movement Disorder International society at Catania in Italy. As a feather in her cap she was invited as a Chief Guest in World Congress of Anatomist held in Gadag Institute of Medical Sciences in Karnataka.

She is a recipient of MRCPCH UK, an internationally acclaimed medical qualification. Her research interest is in complex paediatric epilepsies, ketogenic diet and paediatric movement disorder.

Prof. Harry Steinbusch is appointed as Professor in Cellular Neuroscience at Maastricht University in the Netherlands. He is President of the International Neurotoxicity Society. He is founding editor-in-chief of the Journal of Chemical Neuroanatomy, current i.f. 2.475. He is affiliated with the DGIST in Daegu, Korea; KBSI in Deagon, Korea; USP in Sao Paulo, Brazil; Tohoku University, Sendai, Japan; NIMHANS, Bangalore, India. His research interest is focussed on neurodevelopmental influences towards depression and neurodegenerative diseases studied in animal models approaches to start and prevent neurodegenerative processes. This implies combining a broad range of techniques, i.e. molecular neurobiology, quantitative neuromorphology, animal behavior and epigenetics. He has thus far guided 84 Ph.D. students. He has gathered a total of 475 papers. He has been twice coordinating a Marie Curie Early Stage Training site. Currently. He is coordinator of an Erasmus Mundus + program between 4 Euron universities and 3 universities in Japan. He is affilated on 17 editoriaal board and member of 8 International review committees. His current Hirsch factor is 69 and M-factor is 1.9.

Neurodevelopmental influences towards depression and Neurodegenerative diseases

1. Associate Director Company Name- Neurovascular Imaging Research Core, UCLA Dates Employed- May 2016 Present Employment Duration- 1 yr 6 months 2. Assistant Professor in Residence Company Name- UCLA Dates Employed- Jul 2015 Employment Duration- 2 yrs 4 months Location- Greater Los Angeles Area Department of Neurology and Computer Science 3. Visiting Assistant Professor Company Name- UCLA Dates Employed- Dec 2012 Employment Duration- 4 yrs 11 months Location- Greater Los Angeles Area

His research is directed to Stroke and traumatic brain injuries (TBI) using brain mapping of imaging and biosignals (MR, CT, X-ray angiography, TCD, and ICP).

Experienced Assistant Professor with a demonstrated history of working in the hospital & health care industry. Skilled in Emergency Medicine, Public Speaking, Neurosurgery, Healthcare Information Technology (HIT), and Grant Writing. Strong education professional graduated from Medical University/Medical Academy, Sofia.

Vascular Neurosurgery - brain hemorrhage, aneurysm, AVM, ischemic stroke

Dr. Gavin Britz earned his MBBCh at the University of the Witwatersrand School of Medicine, South Africa in 1987. He completed a surgical internship in general surgery and fellowship in general surgery at Johns Hopkins Hospital, Baltimore in 1993 and in 2002 he completed his residency in neurosurgery. During his residency he attended St. Georges Medical School, The University of London, UK and served as a Neurosurgical Registrar and Senior Registrar. After residency, he took a cerebrovascular fellowship in 2002 and an Interventional Neuroradiology Fellowship in 2003 at the University of Washington Medical School, Seattle. In 2003 he earned his MPH at the University of Washington, Seattle. He also obtained an MBA from George Washington University in 2015. He held faculty appointments at the University of Washington and Duke University before becoming a member of Houston Methodist Research Institute in 2014.

Brain aneurysm, cerebral microcirculation, acute brain injury & evaluating new and novel tools to treat a wide variety of problems such as brain aneurysms and skull base tumors

Prof. Stavros J.Baloyannis was born in Thessaloniki, Greece. He graduated from the School of Medicine of Aristotelian University of Thessaloniki, Postgraduate training (a) in Neurology in Aristotelian University and Institute of Neurology, Queen Square, London, (b) in Neuropathology in Institute of Neurology, Queen Square, Catholic University of Louvain, University of Pennsylvania, Philadelphia (c) in Neurotology and Neuropathology of Auditory pathway in Harvard University, (d). Neuropathology and Experimental Neurology, University of Pennsylvania, (e) Neuroimmunology, Yale University, New Haven. Research on Blood Brain Barrier in dementias, Blood Brain Barrier in Demyelinating diseases, Mitochondria in Alzheimers disease, Synaptogenesis in vivo and in vitro, Neuronal apoptosis in dementias and demyelinating diseases, Dendritic pathology in dementias, Pathology of Golgi apparatus in dementias. Special interests: Neuroethics, Neurolinguistics, Philosophy of Neurosciences, Application of mathematics in Neurosciences, Neurology and the Art. Member of 56 scientific societies in Greece and abroad. Honorary Member of the Academy of Hellenic Air Forces. President of the Society for the amelioration of the quality of life in chronic neurological diseases. President of the Orthodox Medical Association for support of health and medical education in Africa. He was visiting professor in Tufts University, Democretian University, Aristotelian University, School of Theology, Aristotelian University, School of Philosophy. Author of 28 textbooks on Neurology, Neuropathology, Neuropsychology and of 692 papers, published in Greek and International Journals on Neurology, Neuropathology, Neuroimmunology and Neuroethics. Head of the 1st Department of Neurology, Aristotelian University for 20 years (1992-2011). Emeritus Professor of Neurology, Aristotelian University, Thessaloniki, Greece. Director of Research Institute for Alzheimers disease and frontotemporal dementias. Archon Actuarius of the Ecumenical Patriarchate of Constantinople.

Electron Microscopy and Neuropathology of Alzheimers disease, ageing and degenerative conditions of the central nervous system

Dr. Theodore Wein MD, FRCPC, FAHA is an Assistant Professor of Neurology and Neurosurgery at McGill University where he works at the Stroke Prevention Clinic and is a William Osler Fellow. He completed his Neurology training at the Montreal Neurological Institute and went on to do his fellowship in Cerebrovascular Disease at the University of Texas – Houston. Dr. Wein is currently the co chair of the Canadian Stroke Prevention Guidelines and also sits on the Board of the Canadian Stroke Consortium where he heads the Policy and Advocacy committee focused on improving stroke care across Canada. Devoted to education Dr. Wein has chaired the annual American Heart Association International Stroke Conference pre-conference “stroke in the real world” and also sits on the steering Committee of the Canadian Stroke Congress. Dr. Wein is actively involved in stroke clinical trials and has a particular interest in stroke recovery and rehabilitation. He is lead author in the recently completed REFLEX trial looking at efficacy of botulinum toxin in treating post stroke spasticity.

Stroke, Stroke rehabilitation, Spasticity treatment and use of Botulinum Toxin

Krisztián Pozsegovits, M.D. is the chief of service at the Neurology Department of Dr. Kenessey Albert Hospital in Hungary since 2012. Krisztián is a graduate of Semmelweis University, Budapest, Hungary. After graduation he launched his career at the National Institute of Psychiatry and Neurology in Budapest, the cradle of the acute stroke and epilepsy service in Hungary, where he began his neurology training and specialization in stroke from 2002 to 2007. During this period he obtained neurosonology certification, and learnt the basics of research and presentation techniques. He spent 8 months in Akita, Japan as a stroke epidemiology fellow.

Neurology, Medicine & Neuropsychiatry

1. Director/Owner Company Name- Neuro-Psychology Practice, LLC Dates Employed- Jan 2013 – Present Employment Duration- 4 yrs 11 months Location- New York, NY 2. Assistant Professor of Neuroscience Company Name- Seton Hall University Dates Employed- Dec 2010 – Present Employment Duration- 7 yrs 3. Head of Pediatric Neuropsychology Service, JFK Medical Center Company Name- JFK Medical Center, Children's Services Dates Employed- Jan 2012 – Dec 2012 Employment Duration- 12 months Location- Edison, New Jersey 4. Staff Neuropsychologist Company Name- JFK Health Dates Employed- Sep 2007 – Jan 2012 Employment Duration- 4 yrs 5 months Location- Neuroscience Institute, Center for Head Injuries

Neurodevelopmental/neurological disorders, stroke, tumors, brain injury, epilepsy, sleep.

Dr. Altschul is a dual trained open vascular and endovascular neurosurgeon with special focus on the treatment of cerebovascular disease. David Altschul, MD—a graduate of SUNY Downstate College of Medicine in Brooklyn, New York—completed a general surgery internship, neurological surgery residency (he served as chief resident) and a fellowship in Endovascular Neurosurgery at Montefiore. He has a great interest in the open and endoscopic treatment of benign and malignant brain tumors. He is particularly interested in clinical outcomes research using new endovascular technology, as well as participating in multi-center randomized trials for the treatment of intracerebral hemorrhage, aneurysms, and AVMs. Dr. Altschul has a strong interest in resident education, currently acting as the associate residency program director. Dr. Altschul’s future research is heavily involved with potential new treatments of neurological diseases using endovascular technology. He also completed an endovascular neurosurgery fellowship at St. Luke's-Roosevelt Hospital, New York City. Dr. Altschul is one of only a few surgeons in the region trained in both endovascular (interventional) and open neurological surgery for adult and pediatric patients.

Past research has focused on the safety and efficacy of detachable micro-catheters for pediatric AVMs and the development of other minimally invasive technology for treating cerebrovascular disease. Dr. Altschul is currently involved in the ESCAPE trial evaluating endovascular stroke intervention at Montefiore.

He Studied M.B.B.S at R G Kar Medical College, Calcutta, India, Studied MCh Neurosurgery at SCTIMST, Studied Neurosurgery at National Board Certification He is working as Senior Consultant and Head of department of Neurosurgery at Al Qassimi Hospital, Sharjah Former Senior Consultant Neurosurgeon at SUT hospital pattom Former Doctor at R G Kar Medical College and Hospital Former Assistant Professor of Neurosurgery at Trivandrum Former Senior Consultant and Head of Neuroscience at SUT Hospital , Pattom Former Assistant Professor at Sree Chitra Tirunal Institute for Medical Sciences & Technology

Neurosurgery

In 1985 I graduated in Biological Science at the University of Valencia and in 1996 I finished my PhD in the IIC Institute looking for astrogliogenesis during brain development. In 1997 I spent three years at Hallamshire Hospital, Sheffield, UK. I was working in inflammation and regulation of IL-1 and IL-1 receptor. In 2000 I returned to Spain at Department of Physiology, Faculty of Medicine in University of Valencia until now. I am working in toxicity in developmental and neurodegenerative disease (such as Alzheimer’s disease) looking for oxidative stress and inflammation mechanisms

Toxicity in developmental and Neurodegenerative disease (such as Alzheimer’s disease) looking for oxidative stress and inflammation mechanisms

Dr. Pappolla's training included 3 complete medical residencies and 2 fellowships (Neurology, Clinical Pathology, Anatomic Pathology, Neuropathology, Pain Medicine), a PhD in human aging with a postdoc/sabbatical in molecular biology and over 20 years of academic practice. He holds active board certifications in these 5 areas (Neurology, Clinical Pathology, Anatomic Pathology, Neurology, Pain Medicine). Some of his research work is cited in several thousand textbooks worldwide, with many papers reaching from 300 to over 1000 citations in peer reviewed journals. His lab was among the first to identify evidence of oxidative stress in Alzheimer's disease brain. In collaborations with Dr. Larry Refolo, Dr Suzana Petanceska at the NIH, Dr. Daniel Zambon in Spain and others, we conducted groundbreaking research on hypercholesterolemia as an early risk factor for Alzheimer's disease. As a neuropathologist, he described several unique neuropathologic lesions including the colloid body of Parkinson's disease (later renamed "pale body") and the ubiquitinilated "dot like inclusions" in aged brains. One other important contribution was the development of neuroprotective drugs as potential therapeutic agents. He identified of several naturally occurring neuroprotective substances like indole-3-propionic acid and others. Dr. Pappolla served as a consultant for the National Institutes of Health in the United States including being a chartered member of numerous study sections for over 25 years and as a full professor or faculty at several medical schools (LSU New Orleans, Mount Sinai Medical School in New York City, University of Texas) where he taught Neurosciences to medical students and medical residents for over 20 years. Currently, he holds a hybrid academic-private practice position in the Houston area. Dr. Pappolla can be contacted at www.SMPSClinic.com

Alzheimer's Disease, Neuropathology, Interventional Pain Management

Dr. Michael Behen is an Assistant Professor of Pediatrics and Neurology at Wayne State University. He is a Neuropsychologist of the PET Center and manages research, teaching, and supervision of graduate students and postdocs along with neuropsychological assessments and treatment of psychiatric conditions. Dr. Behen completed his PhD in Psychology (Clinical) from Wayne State University and a fellowship in Children’s Hospital of Michigan-PET Center/Pediatrics, Neurology.

Psychology, Neurology

I completed a master degree in "cellular biology and physio-pathology" in Paris with a specialization in neurosciences, before preparing a PhD at the University of Amiens (north France). During this phD I have studied the developpement of a central nervous system cancer (C6 glioma) on a rat model, in combination to the exposure to an environmental factor (Electromagnetic fields). The analyzed parameters were behavioral, histological, and biochemical. In the future I would like to shift towards the understanding of cellular or molecular mechanisms that underlie toxicity and neurological diseases.

Neurobiology, Neurotoxicology.

Dr. Marek Czosynka is a Professor of Clinical Neurosciences Department at University of Cambridge.

Brain Autoregulation, Cerebrospinal fluid dynamics, Multi-modal brain monitoring (head trauma, poor grade SAH, stroke), Mathematical modeling of cerebrospinal dynamics, Hydrodynamic properties of hydrocephalus shunts, Software for brain monitoring

Mr. Pauls has served as President, Chief Executive Officer, and director since 2010 and was Chairman of the board from 2008 to 2014. Mr. Pauls was previously the co-founder and Managing Director of CentreStone Ventures Inc., a life sciences venture capital fund. Prior to CentreStone, he was with Centara Corporation, another early stage venture capital fund. Before this, Mr. Pauls specialized in asset-backed securitization and structured finance at the General Motors Acceptance Corporation in Minnesota. He received his Bachelor of Arts in Economics from the University of Manitoba and his M.B.A. in Finance from the University of North Dakota.

biopharmaceutics